These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20458574)

  • 1. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
    Allen MR; Kubek DJ; Burr DB; Ruggiero SL; Chu TM
    Osteoporos Int; 2011 Feb; 22(2):693-702. PubMed ID: 20458574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.
    Allen MR; Chu TM; Ruggiero SL
    J Oral Maxillofac Surg; 2013 Jun; 71(6):1017-26. PubMed ID: 23375897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
    Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
    J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw.
    Biasotto M; Chiandussi S; Zacchigna S; Moimas S; Dore F; Pozzato G; Cavalli F; Zanconati F; Contardo L; Giacca M; Di Lenarda R
    J Oral Pathol Med; 2010 May; 39(5):390-6. PubMed ID: 20202091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
    Gibbs SD; O'Grady J; Seymour JF; Prince HM
    Med J Aust; 2005 Nov; 183(10):549-50. PubMed ID: 16296983
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner.
    Kozutsumi R; Kuroshima S; Kaneko H; Sasaki M; Ishisaki A; Sawase T
    Calcif Tissue Int; 2022 Jan; 110(1):104-116. PubMed ID: 34363509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
    Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
    J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
    Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
    Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
    Huja SS; Mason A; Fenell CE; Mo X; Hueni S; D'Atri AM; Fernandez SA
    J Oral Maxillofac Surg; 2011 Feb; 69(2):418-27. PubMed ID: 21122971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.
    Allen MR
    Odontology; 2011 Jan; 99(1):8-17. PubMed ID: 21271320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.
    Bi Y; Gao Y; Ehirchiou D; Cao C; Kikuiri T; Le A; Shi S; Zhang L
    Am J Pathol; 2010 Jul; 177(1):280-90. PubMed ID: 20472893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.
    Wong YK; Cheng JC
    Quintessence Int; 2008 Mar; 39(3):195-201. PubMed ID: 18618033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
    Statz TA; Guthmiller JM; Humbert LA; Johnson GK
    J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
    Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
    PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates-related jaw osteonecrosis].
    Abi Najm S; Lysitsa S; Carrel JP; Lesclous P; Lombardi T; Samson J
    Presse Med; 2005 Sep; 34(15):1073-7. PubMed ID: 16334883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
    Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
    BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
    Olson KB; Hellie CM; Pienta KJ
    Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.